Medical News Today: Breast cancer screening saved over 27,000 lives in 2018

A new study estimates that breast cancer mortality rates have fallen by approximately half in the United States in 2018, thanks to screening and therapy.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Breast Cancer Source Type: news

Related Links:

Condition:   Breast Cancer Intervention:   Sponsor:   Cancer Trials Ireland Recruiting
Source: - Category: Research Source Type: clinical trials
Cellular barcoding shows promise as a way to identify the few metastasis-driving cell variants from the thousands that are present in breast cancer tumors.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Breast Cancer Source Type: news
Condition:   Breast Cancer Interventions:   Drug: Promensil;   Drug: Placebo Oral Tablet Sponsor:   Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Completed
Source: - Category: Research Source Type: clinical trials
(Natural News) Eating an array of colorful fruits and vegetables is an integral part of any healthy diet, but some of the most potent cancer-fighting compounds can be found in warm-hued produce. Carotenoids are predominately found in foods that are red, orange and yellow — though some leafy greens are also a great source of...
Source: - Category: Consumer Health News Source Type: news
Evidence suggests that breast cancer survivors are at risk for anxiety, depression, and suicide.Journal of the National Cancer Institute
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Jesse D. Plotkin, Michael G. Elias, Mohammad Fereydouni, Tracy R. Daniels-Wells, Anthony L. Dellinger, Manuel L. Penichet, Christopher L. Kepley
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
Authors: Zhang J, Zhang H, Luo Y Abstract BACKGROUND The aim of this study was to investigate the clinical correlation between sPD-1 (soluble programmed cell death-1) and PD-1 (programmed cell death-1) expression and cancer pain. MATERIAL AND METHODS sPD-1 content in peripheral blood was determined by enzyme-linked immunosorbent assay (ELISA). T cell surface-positive rate was determined by flow cytometry, and the correlation of clinical characteristics of patients with cancer pain was analyzed. RESULTS The positive expression rate of PD-1 in sPD-1 and T cells of patients with cancer pain was higher than that in nor...
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
mig Kasimir-Bauer Liquid biopsy analytes such as cell-free DNA (cfDNA) and circulating tumor cells (CTCs) exhibit great potential for personalized treatment. Since cfDNA and CTCs are considered to give additive information and blood specimens are limited, isolation of cfDNA and CTC in an “all from one tube” format is desired. We investigated whether cfDNA variant sequencing from CTC-depleted blood (CTC-depl. B; obtained after positive immunomagnetic isolation of CTCs (AdnaTest EMT-2/Stem Cell Select, QIAGEN)) impacts the results compared to cfDNA variant sequencing from matched whole blood (WB). ...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Article Source Type: research
AbstractPurposeWe developed a heart atlas for breast radiation therapy and evaluated the influence of education on intra and inter-observer similarity, and cardiac dose reporting.Materials and methodsThe data of 16 left breast cancer patients were analyzed. Eight observers delineated heart and cardiac subunits [left (LCA) and right (RCA) coronary arteries, left anterior descending artery (LAD), bilateral atrium and ventricles] before the education. A radiologist and radiation oncologist developed the atlas and delineated the gold standard (GS) volumes. Observers repeated the delineation after education. RT plans were made ...
Source: Japanese Journal of Radiology - Category: Radiology Source Type: research
In this study, we aimed to establish two effective strategies for identifying breast cancer genes based on the systems genetics algorithm. As a result, we found that the GeneRank-based strategy, which combines the prognostic phenotype-based gene-dependent network with the phenotypic-related PheWAS data, can promote the identification of breast cancer genes and the discovery of anti-breast cancer drugs.
Source: Genes - Category: Genetics & Stem Cells Authors: Tags: Letter Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Health | Study | USA Health